Back to News
Market Impact: 0.35

BMO reiterates Workday stock rating on strong sales execution

Corporate EarningsAnalyst InsightsAnalyst EstimatesCompany FundamentalsCorporate Guidance & OutlookArtificial IntelligenceProduct LaunchesTechnology & Innovation
BMO reiterates Workday stock rating on strong sales execution

BMO Capital reiterated an Outperform on Workday with a $182 price target, while the stock trades at $121.85. Fiscal Q1 results beat expectations, with gross margin at 75.7% and the highest first-quarter new annual contract value growth in five years, alongside improving AI contribution and demand. Management left fiscal 2027 subscription guidance unchanged but raised operating margin guidance by 50 bps, and Sana is set to roll out to customers this month.

Analysis

WDAY is showing a classic multiple-re-rating setup: the core business is de-risking while the market is still pricing it as a slowing enterprise software name. The key second-order effect is that stronger execution plus AI contribution shifts the debate from “does AI cannibalize seat growth?” to “how much of the backlog can be monetized through higher attach and workflow expansion,” which supports both NRR durability and a higher terminal margin assumption. That matters because a 50bps operating margin step-up on a large subscription base compounds quickly over the next 6-8 quarters and can lift EPS faster than topline growth alone would imply. The near-term catalyst path is still mostly about estimate revisions and sentiment repair, not heroic beats. With a depressed stock price and upward analyst revisions, even modest quarterly outperformance can force systematic buyers back in, especially if management continues to frame AI as incremental monetization rather than a cost center. The biggest tell over the next 1-2 quarters will be whether deal linearity and ACV strength persist without extra discounts; if they do, the market may have to unwind the bear case that this is a low-growth mature SaaS compounder. The contrarian risk is that enthusiasm around Sana and AI can mask the fact that buyers will demand evidence of monetization, not just product narrative. If AI features accelerate sales cycles but do not improve average deal size, the stock can stall despite positive headlines; that would be most visible in RPO and billings conversion over the next two reporting cycles. A second risk is that the current valuation recovery could get ahead of itself if the Street decides the guidance raise is mostly a margin story rather than a durable demand story. Second-order beneficiaries could include adjacent enterprise workflow/software names if the market starts re-pricing the group on durable AI attach rates rather than feared displacement. The real competitive implication is that vendors with weak AI roadmaps may need to spend more on product development and go-to-market incentives to defend share, which could pressure margins across the category over the next 12 months.